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Shiga toxin-producing Escherichia coli (STEC) may cause bloody diarrhea and hemorrhagic
colitis (HC), with subsequent systemic disease. Since genes coding for Shiga toxins
(stx genes) are located on lambdoid prophages, their effective production occurs only
after prophage induction. Such induction and subsequent lytic development of Shiga
toxin-converting bacteriophages results not only in production of toxic proteins, but also
in the lysis (and thus, the death) of the host cell. Therefore, one may ask the question:
what is the benefit for bacteria to produce the toxin if they die due to phage production
and subsequent cell lysis? Recently, a hypothesis was proposed (simultaneously but
independently by two research groups) that STEC may benefit from Shiga toxin production
as a result of toxin-dependent killing of eukaryotic cells such as unicellular predators or
human leukocytes. This hypothesis could make sense only if we assume that prophage
induction (and production of the toxin) occurs only in a small fraction of bacterial cells,
thus, a few members of the population are sacrificed for the benefit of the rest, providing
an example of “bacterial altruism.” However, various reports indicating that the frequency
of spontaneous induction of Shiga toxin-converting prophages is higher than that of other
lambdoid prophages might seem to contradict the for-mentioned model. On the other
hand, analysis of recently published results, discussed here, indicated that the efficiency
of prophage excision under conditions that may likely occur in the natural habitat of STEC
is sufficiently low to ensure survival of a large fraction of the bacterial host. A molecular
mechanism by which partial prophage induction may occur is proposed. We conclude that
the published data supports the proposed model of bacterial “altruism” where prophage
induction occurs at a low enough frequency to render toxin production a positive selective
force on the general STEC population.
Keywords: enterohermorrhagic Escherichia coli, Shiga toxin, lambdoid bacteriophages, prophage induction,
bacterial altruism
BACKGROUND
Escherichia coli is a Gram-negative bacterium, commonly known
as an intestinal commensal of mammals including humans.
However, some E. coli strains are pathogenic to humans. These
include the Shiga toxin-producing E. coli (STEC), particularly a
subset of strains classified as enterohemorrhagic E. coli (EHEC).
The development of severe diseases such as the hemolytic ure-
mic syndrome (HUS) and hemorrhagic colitis (HC) by these
strains, including the most intensively studied serotype O157:H7,
depends on production of Shiga toxins (Hunt, 2010).
HUS and HC are possible complications of infection of
humans by EHEC (Gyles, 2007). Children and elderly people
are the groups at highest risk for HUS. Among patients infected
with EHEC and suffering from diarrhea, 3–15% develops HUS
Abbreviations: EAEC, enteroaggregative Escherichia coli; EHEC, enterohemor-
rhagic Escherichia coli; pfu, plaque forming units; ER, endoplasmic reticulum;
STEC, Shiga toxin-producing Escherichia coli; HC, hemorrhagic colitis; HUS,
hemolytic uremic syndrome.
(Razzaq, 2006). This syndrome is characterized by acute renal
failure, hemolytic anemia, and thrombocytopenia. Other organs
such as the lung, pancreas, and heart may also be damaged.
Moreover, some patients suffer additionally from nervous sys-
tem dysfunctions, which may include lethargy or disorientation
(Obata et al., 2008 and references therein). Mortality of patients
with STEC-associated HUS has been estimated at up to 10%
(Razzaq, 2006; Gyles, 2007).
The severity of EHEC-associated disease can be exempli-
fied by the recent outbreak that occurred in Germany in 2011,
when out of about 4000 symptomatic infections, 50 patients
died (Mellmann et al., 2011; Beutin and Martin, 2012; Bloch
et al., 2012; Karch et al., 2012; Werber et al., 2012). In fact, the
strain which caused that outbreak was of the O104:H4 serotype
and produced a combination of virulence factors characteris-
tic of enteroaggregative E. coli (EAEC) and EHEC (reviewed by
Karch et al., 2012). It appears that this strain was EAEC which
acquired stx genes by lysogenizationwith a Shiga toxin-converting
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bacteriophage (Laing et al., 2012). The specific combination of
enhanced adhesion, survival fitness, antibiotic resistance, and
Shiga toxin production may explain the high virulence of this
particular strain (Karch et al., 2012). This also underlines the
importance of Shiga toxins to the virulence of E. coli strains,
which would otherwise be significantly less dangerous to humans.
Shiga toxins are proteins consisting of two types of sub-
units, A and B, forming a heterohexamere composed of a single
A-subunit and five B-subunits (AB5). The C-terminal part of the
A-subunit is anchored to the B-subunit pentamer (Law, 2000).
B-subunits recognize a specific cell-surface receptor (Gb3) on
eukaryotic cells. The toxin enters Gb3 expressing cells by receptor-
mediated endocytosis, following which it is translocated via the
endosome to the lysosome for degradation, or it undergoes ret-
rograde transport from the early endosome through the Golgi-
apparatus and to the endoplasmic reticulum. In the latter case,
there is an initial proteolytic cleavage of the A-subunit, resulting
in formation of an A1 fragment connected to an A2 fragment
by a disulfide bond. The A2 fragment remains associated with
the B pentamer, and this complex is released from A1 follow-
ing reduction of the disulfide bond (which probably occurs in
the endoplasmic reticulum). Thus, the A1 polypeptide is translo-
cated from the ER to the cytoplasm (for a detailed description
of the retrotranslocation and processing of Shiga toxin, see the
following references: Garred et al., 1995a,b, 1997; LaPointe et al.,
2005; Yu and Haslam, 2005; Tam and Lingwood, 2007). In the
cytoplasm, this toxin acts as an N-glycosidase that depurinates
the sarcin/ricin loop of a single adenine residue in the 28S
rRNA (Obrig et al., 1987; Endo et al., 1988). This causes an
inhibition of binding of amino-acyl-tRNA to the ribosome and
cessation of protein synthesis, leading to cell death (for a review,
see Law, 2000).
Contrary to many other virulence factors, genes encoding
Shiga toxins (stx genes) are not of E. coli chromosome origin,
but are part of lambdoid prophages (Allison, 2007). In a major-
ity of STEC strains analyzed to date, the stx genes are under
control of the late phage promoter, pR′ (Wagner et al., 2001a,
2002). In lambdoid phages, the expression of most genes (except
for cI in all lambdoid phages, and a few genes in other phages)
is strongly inhibited in the prophage state, due to the activ-
ity of the cI repressor (Ptashne, 2004; We˛grzyn and We˛grzyn,
2005; Riley et al., 2012). Thus, in bacteria lysogenic for Shiga
toxin-converting bacteriophages, expression of the stx genes is
repressed. This implies that production of Shiga toxins must be
preceded by prophage induction, which has been demonstrated
by Herold et al. (2004) and Waldor and Friedman (2005). It is
worth reminding that the most efficient induction of lambdoid
prophages occurs under conditions that induce the bacterial SOS
response (a response to DNA damage or DNA synthesis per-
turbation) and is dependent on the host-encoded RecA protein
(Ptashne, 2004; We˛grzyn et al., 2012).
The regulatory mechanism described above raised an intrigu-
ing question. Namely, induction of a lambdoid prophage leads
irreversibly to bacteriophage lytic development, which ends with
production of progeny virions and their liberation after host cell
lysis (Ptashne, 2004; We˛grzyn and We˛grzyn, 2005). Actually, lysis
allows for the effective release of Shiga toxins. However, this
means that a bacterial cell producing Shiga toxin must die
before large quantities of the toxin can act as a virulence factor.
Therefore, one might ask what is the benefit for a bacterium to
produce Shiga toxin if its death is strongly coupled to stx expres-
sion? If there is no such benefit, one might predict a selective
pressure against toxin-producing bacteria, resulting in accumula-
tion of mutations in stx genes and eventual elimination of STEC
from the environment. However, this is not the case, and there-
fore it would be expected that E. coli should incur a benefit
from lysogeny by Shiga toxin-converting phages. Recently, two
different groups proposed (simultaneously but independently) a
hypothesis explaining how STEC might benefit from Shiga toxin
production (Łos´ et al., 2011; Mauro and Koudelka, 2011). The
hypothesis is that Shiga toxin protects STEC from attack by uni-
cellular predators and possibly neutrophils (although Shiga toxin
has not been shown to be directly toxic to neutrophils, its pro-
duction might be a response to neutrophil-mediated attack). This
hypothesis, while perhaps intriguing, might also be recognized as
controversial, as it could be difficult to prove it in the laboratory.
Nevertheless, if true, the hypothesis should be compatible with
existing experimental data. Therefore, in our opinion, it requires
an assessment of probability in light of published results.
IS VIRULENCE OF STEC TO HUMANS COINCIDENTAL?
Although STEC strains produce virulence factors and cause severe
symptoms in infected humans, they might be assessed as non-
classical human pathogens. This is because human-to-human
transmission of STEC is relatively rare outside of an outbreak
situation and therefore is probably insufficient to sustain popula-
tions of these bacteria (Brandl, 2006; Vaillant et al., 2009; Aldabe
et al., 2011; Locking et al., 2011; Rotariu et al., 2012). In fact,
cattle and other ungulates, to which these bacteria are usually
non-pathogenic, are considered natural hosts for STEC (Dean-
Nystrom et al., 1988; Hancock et al., 1988). Therefore, Brandl
(2006) has proposed that STEC virulence in humans is coinci-
dental with the biological role for Shiga toxin being unrelated to
human infection. According to this hypothesis, synthesis of Shiga
toxins by E. colimay enhance survival of bacteria in food vacuoles
of protozoan predators. In fact, results of subsequent experimen-
tal studies indicate that the presence of Shiga toxin-converting
prophages augment the fitness of E. coli in the presence, but
not the absence, of a protozoan predator, Tetrahymena pyriformis
(Steinberg and Levin, 2007). Moreover, the carriage of the stx gene
on a prophage increased the rate of bacterial survival in the food
vacuoles of this ciliate (Steinberg and Levin, 2007).
Similar studies additionally support a role for stx genes in the
survival of E. coli outside the human intestine. It was demon-
strated that another bacterivorous, protozoan predator, T. ther-
mophila, was killed when co-cultured with bacteria lysogenic
with Shiga toxin-converting bacteriophage (Lainhart et al., 2009).
Interestingly, this eukaryotic unicellular predator died in the pres-
ence of purified Shiga toxin, strongly suggesting that this toxin
may be used as an anti-predator agent by bacteria. It is possi-
ble that the mechanism by which Shiga toxin kills Tetrahymena
is analogous to that resulting in toxicity to human cells.
Another interesting observation was that in the presence
of catalase, an enzyme that breakdowns hydrogen peroxide,
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STEC-dependent Tetrahymena killing in co-cultures diminished
(Lainhart et al., 2009). Tetrahymena is known to produce H2O2
(Fok and Allen, 1975), which may be used to damage bacterial
cells during attack by this predator, however, one might speculate
that if Shiga toxin-converting prophages are induced by hydro-
gen peroxide, this strategy is not effective. In fact, recA mutations
in E. coli, which prevented the bacterial SOS response [a pro-
cess required to trigger lambdoid prophage induction (Ptashne,
2004;We˛grzyn andWe˛grzyn, 2005)], protected Tetrahymena from
being killed in co-cultures with STEC (Lainhart et al., 2009).
Moreover, induction of lambdoid prophages was demonstrated
experimentally in hydrogen peroxide-treated lysogenic bacteria
(Łos´ et al., 2009, 2010).
THE HYPOTHESIS
The results summarized in the preceding subsection suggest
that production of hydrogen peroxide by eukaryotic unicellular
predators, like Tetrahymena, may induce Shiga toxin-converting
prophages in STEC, resulting in production and release of Shiga
toxin. These data provided a basis for the hypothesis that under
such conditions, the predator would be killed, which might be
beneficial for the bacteria (Łos´ et al., 2011; Mauro and Koudelka,
2011). If we consider that infection of humans by STEC is coin-
cidental, one might ask why these bacteria produce Shiga toxins
in the intestine? As suggested by the authors of this bacterial
“altruism” hypothesis, the occurrence of hydrogen peroxide in
the human intestine during infection is possible since human
neutrophils may produce H2O2 in response to STEC (Wagner
et al., 2001b), a strategy similar to that used by Tetrahymena
to hunt bacteria. Moreover, it was demonstrated that bacteria
present in the human intestine can cause the generation of reac-
tive oxygen species (Kumar et al., 2007). Therefore, the hypothesis
can be presented schematically as shown in Figure 1. However,
since prophage induction leads to lytic development and killing
of the host cell, the problem with the hypothesis is that it is diffi-
cult to imagine how already dead bacteria may benefit from killing
a predator or neutrophils (or other human cells). Therefore, the
bacterial “altruism” hypothesis presented here (Figure 1) requires
that prophage induction only occur in a small fraction of the
STEC population. So, what is the experimental evidence rejecting
or supporting this model?
ARGUMENTS AGAINST THE HYPOTHESIS
A necessary condition of the hypothesis, i.e., that there can be
minimal STEC prophage induction, might appear unlikely in
the light of certain published data. Namely, it was demonstrated
that in E. coli, the spontaneous induction (i.e., without treat-
ment of lysogenic cells by any specific induction agent) of Shiga
toxin-converting prophages is significantly more frequent than
that of other known lambdoid prophages (Livny and Friedman,
2004; Shimizu et al., 2009). Moreover, specific conditions, such
as high hydrostatic pressure, can induce prophages carrying Shiga
FIGURE 1 | The model of STEC altruism, representing the hypothesis on
the benefit which E. coli lysogenic with Shiga toxin-converting phages
may gain from production of Shiga toxins coupled with prophage
induction and subsequent cell death. (A) A protozoan predator
(exemplified by Tetrahymena) releases hydrogen peroxide to damage
bacterial cells. (B) In the case of STEC, hydrogen peroxide causes induction
of Shiga toxin-converting prophage in a small fraction of bacterial cells, which
is, nevertheless, sufficient to produce Shiga toxins (Stx) in amounts enough
to kill the predator. (C) Neutrophils employ a strategy similar to that used by
protozoan predators if human intestine is infected with bacteria recognized as
aliens. (D) The response of STEC to neutrophils’ attack is analogous to that
employed by this bacterium to faith against unicellular eukaryotic predators.
The original hypothesis was presented in two articles (Łos´ et al., 2011; Mauro
and Koudelka, 2011).
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toxin genes (Aertsen et al., 2005). As demonstrated recently, these
prophages can also be induced in a RecA-independent manner
with the chelating agents, EDTA or citrate, and various chelat-
ing compounds may occur in the human intestine (Imamovic
and Muniesa, 2012). Furthermore, unlike E. coli lysogenic with
λ and some other lambdoid phages, STEC are known to often
harbor more than one Shiga toxin-converting prophage, and
double lysogens were recently demonstrated to be more sen-
sitive to inducing agents than single lysogens (Fogg et al.,
2012). This suggests that maintenance of a stable prophage is
less likely when multiple phage genomes are inserted into the
E. coli chromosome. These results indicate that in the absence
of specific agents promoting prophage induction, Shiga toxin-
converting prophages are less stable in E. coli hosts than other
lambdoid prophages. Moreover, additional mechanisms of RecA-
independent prophage induction could exist in phages bearing
Shiga toxin genes. Therefore, the hypothesis under debate might
appear doubtful.
Some STEC strains, including E. coli O157, are able to sur-
vive and replicate inside protozoal cells, specifically the common
protozoan Acanthamoeba polyphaga (Barker et al., 1999), and
another protozoan species, A. castellani, have been demonstrated
to be hosts for E. coli O157:H7 (Carruthers et al., 2010). These
observations corroborate data presented in previous publica-
tions, which suggested that protozoa can be hosts for bacteria,
including those pathogenic to humans (Barker and Brown, 1994;
Lloyd et al., 1996). Therefore, one might assume that growth
of pathogenic bacteria inside protozoan cells could enhance the
environmental survival of these prokaryotes. Accordingly, it has
been proposed that the residing of pathogenic bacteria within
protozoa may increase bacterial virulence and resistance to antibi-
otics (Barker and Brown, 1994; Lloyd et al., 1996). On the other
hand, when studying interactions between rumen ciliates and
STEC, Burow et al. (2005) failed to detect STEC-specific DNA
in protozoal fractions after fractionation of the co-cultures. They
concluded that ruminal protozoa are unlikely to be a major factor
in the survival of STEC in ruminants. Nevertheless, they also con-
cluded that these ciliates are neither hosts nor predators to STEC
(Burow et al., 2005). These data suggest that if ruminal mammals
are natural hosts for STEC, then the ciliates present are not likely
predators of STEC.
ARGUMENTS FOR THE HYPOTHESIS
Although Shiga toxin-converting prophages undergo sponta-
neous induction more frequently than other lambdoid phages
(see previous subsection), the actual frequency of the switch from
lysogenic to lytic development in an untreated bacterial host is
still low (Livny and Friedman, 2004; see also Łos´ et al., 2011).
It was estimated that spontaneous induction occurs in approxi-
mately 0.005% of cells per generation in bacteria lysogenic with
the Shiga toxin-converting phage H-19B (Livny and Friedman,
2004). Therefore, in light of the discussed hypothesis, it is impor-
tant to consider what fraction of lysogenic cells is subjected to
prophage induction under the specific conditions resulting in
enhanced Shiga toxin production.
It was found that among the many tested factors and condi-
tions that are potentially present in the human intestine during
a bacterial infection, hydrogen peroxide is a potent stimulator
of lambdoid prophage induction (Łos´ et al., 2009). However,
comparison of the efficiency of prophage induction after treat-
ment of lysogenic bacteria with either H2O2 or mitomycin
C (an antibiotic employed in laboratories as an efficient SOS
inducer when administered at relatively high concentrations)
revealed that H2O2 is significantly less effective in both labo-
ratory E. coli strains (Łos´ et al., 2009) and a natural isolate of
STEC (Łos´ et al., 2010). Based on these results, under optimal
prophage inducing concentrations of H2O2 (3mM), induction
occurs at most in a small percentage of cells (the highest cal-
culated value was 1.6%, Table 1). In contrast to that of H2O2,
treatment of bacteria with mitomycin C (1μg/ml) induces lytic
development in about 10–30% of lysogenic cells in the culture
(Table 1). In fact, these values are still significantly higher than
those calculated for bacteriophage λ (Table 1), corroborating the
conclusions from previous reports on lower stability of Shiga
toxin-converting prophages. Nonetheless, during treatment of
STEC with hydrogen peroxide only a small fraction of bacterial
population is killed due to prophage induction, which is still suf-
ficient to produce relatively large amounts of Shiga toxin due to
intensive replication of phage DNA and transcription from phage
promoters during lytic development (Nejman et al., 2009, 2011;
Nejman-Falen´czyk et al., 2012).
Interestingly, when we analyzed other published results, it
appeared clear that conditions expected to occur naturally (i.e.,
not only in laboratories, like high concentration of mitomycin C)
can provoke prophage induction at low frequencies. As previ-
ously discussed, adding chelating compounds, such as EDTA,
to STEC cultures promotes phage induction and results in high
titers of Shiga toxin-converting phage (Imamovic and Muniesa,
2012). However, considering that the average phage lytic cycle
produce roughly 100 pfu/cell, re-evaluation of the formentioned
study (Imamovic and Muniesa, 2012) suggests that prophage
induction occurs in at most 1% of cells. This is over an order
of magnitude less than in experiments performed with mito-
mycin C (Imamovic and Muniesa, 2012). Therefore, it appears
Table 1 | Efficiency of prophage induction after treatment of E. coli
lysogenic cells with various compounds.
Bacteriophagea Calculated fraction of induced lysogenic cells
3% H2O2 1µg/ml mitomycin C
λ 0.03% 1.5%
24B 0.3% 11%
933W 0.03% 17%
P22 1.6% 32%
P27 0.1% 24%
P32 0.2% 28%
The calculation is based on previously reported results (Łos´ et al., 2009), and
represents an estimated average fraction of cells in which prophage has been
induced, assuming equal efficiency of progeny phage formation in every cell.
aBacteriophages 24B, 933W, P22, P27, and P32 were originally isolated as
Shiga toxin-converting phages from lysogenic STEC strains (for details, see Łos´
et al., 2009, and references therein).
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that the requirement of low efficiency prophage induction
in combination with effective toxin production may occur
following exposure to naturally occurring agonists of prophage
induction.
When considering the survival or even growth of STEC
inside cells of protozoan microorganisms (Barker et al., 1999;
Carruthers et al., 2010), one should take into consideration that
some protozoans might have a commensal/symbiotic interac-
tion with STEC while others may predate on STEC. Thus, while
E. coli strains may benefit from interactions with A. polyphaga
and A. castellani (hosts), they may be at risk interacting
with T. pyriformis or T. thermophila (predators). Interestingly,
Carruthers et al. (2010) found that expression of stx genes
was enhanced in STEC occurring inside A. castellani cells rel-
ative to planktonic cultures. This may suggest that a proto-
zoan cell is not necessarily an optimal habitat for STEC, and
that there could be various interactions between the eukaryotic
host and the bacterium, which may not be beneficial to both
organisms.
The conclusions presented by Burow et al. (2005) that rumi-
nal protozoa are neither hosts nor predators for STEC require
additional comments. First, the mixed protozoan-bacterial cul-
tures, used in their experiments, contained representatives of only
two genera of ciliates: Entodinium and Epidinium. Although they
started the protozoan cultures from faeces of sheep and cattle,
no other genera present in the original rumen fluid had estab-
lished growth in the mixed culture (Burow et al., 2005). Thus,
one may speculate that Entodinium and Epidinium cannot host
STEC while some other ruminal protozoans can. Therefore, the
conclusion about a lack of STEC hosting by protozoans in the
rumen may be valid for Entodinium and Epidinium but not
necessarily for other genera. Furthermore, the lack of interac-
tions between the ciliates mentioned above and STEC, observed
by Burow et al. (2005), could be caused by factors other than
the absence of specific phenomena in the rumen. For example,
these protozoans might be unable to produce hydrogen per-
oxide, in contrast to Tetrahymena, thus they may not induce
production of Shiga toxins. Also, Entodinium and Epidinium
could be more resistant to Shiga toxins than other genera of
protozoans. Alternatively, the inability of other ruminal proto-
zoa to grow in a mixed culture with STEC could result from
these protozoans being killed by Shiga toxins. If these specula-
tions are true, they could provide an alternative explanation to
the results reported by Burow et al. (2005) that suggests a lack
of major influence by ruminal protozoa on the survival of STEC
in ruminants.
Second, the method of STEC detection in the protozoan frac-
tion after fractionation of the mixed culture was based on PCR-
mediated amplification of stx genes. The authors (Burow et al.,
2005) assumed that if STEC occurred inside protozoan cells, it
would be possible to detect stx-specific signals. However, while
this assumption should be true in the case of living bacteria, the
digestion of bacteria by the ciliate might result in DNA degrada-
tion and therefore no detection by PCR. Therefore, although the
conclusion about a lack of effective colonization of Entodinium
and Epidinium by STEC appears true, a lack of predatory
interactions between these ciliates and STEC can still be argued,
and it is obvious that predatory interactions occur between other
protozoans, like Tetrahymena, and STEC (Steinberg and Levin,
2007; Lainhart et al., 2009). The remaining question is whether
STEC strains are endangered by protozoan predators only outside
the mammalian digestive tract. In summary, although it might
appear that previous reports on interactions between protozoan
and bacterial cells were incompatible with the hypothesis, more
detailed analysis of the published results indicated that this is not
the case. Therefore, the hypothesis may still be true and com-
patible with reported observations on various STEC-protozoan
relations.
ARE THERE OTHER BENEFITS TO STEC FROM SHIGA TOXIN
PRODUCTION?
The hypothesis under debate assumes that the main role for Shiga
toxin production is protecting STEC against either protozoan
predators or (perhaps incidentally) the mammalian immuno-
logical system. However, are there other benefits to bacteria
possible?
An interesting proposal has been made by Robinson et al.
(2006). They have demonstrated in vitro that the stx2mutant of a
STEC strain was less effective in adherence to epithelial cells than
its wild-type counterpart. Moreover, the mutant revealed a lower
capacity to colonize mouse intestine. Therefore, it was concluded
that Shiga toxin promotes intestinal colonization, possibly also
in humans (Robinson et al., 2006). Some earlier results, indicat-
ing specific mutations that reduce adherence of STEC to human
colonic epithelial cells (Scott et al., 2003), might also corroborate
such a conclusion. In contrast to the proposal of Robinson et al.
(2006), experiments performed by Sheng et al. (2006) indicated
that E. coli O157:H7 requires the presence of intimin, Tir and
plasmid pO157 to colonize cattle at the terminal rectal mucosa,
while the colonization proceeded normally in the absence of the
active stx genes.
Even if we assume that Shiga toxin helps bacteria colonize the
human intestine, there is still the question concerning the ben-
efit of stx expression in lieu of cell death following prophage
induction. Thus, the hypothesis under debate may still be attrac-
tive despite the putative involvement of Shiga toxin in facilitating
colonization of the intestine. Interestingly, it was demonstrated
that commensal bacteria present in the human intestine can
induce the generation of reactive oxygen species (Kumar et al.,
2007). If this is the case during the colonization by STEC, the
resulting oxidative stress might cause induction of Shiga toxin-
converting prophage in a small fraction of bacterial cells, with
subsequent production and liberation of significant amounts of
the toxin.
PUTATIVE MOLECULAR MECHANISM FOR LOW EFFICIENCY
PROPHAGE INDUCTION
If the bacterial “altruism” hypothesis under debate is true, it
should be possible to propose a putative mechanism for low
efficiency lambdoid prophage induction under natural “induc-
tive” conditions, such as H2O2 exposure. To elaborate a possible
molecular model for such regulation, one needs to find either
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conditions or a specific experimental system in which efficiency
of prophage induction provoked by hydrogen peroxide would be
similar to that caused by “strong” inductors (like mitomycin C).
In fact, studies on bacteriophage λ, a close relative to Shiga toxin-
converting phages, demonstrated that induction of the prophage
by H2O2 is over 2 orders of magnitude more efficient in E. coli
oxyRmutants than in wild-type hosts (Glinkowska et al., 2010).
The OxyR protein (the oxyR gene product) is a transcrip-
tion regulator and a major regulatory factor stimulated during
oxidative stress (Chiang and Schellhorn, 2012). This regulator
has been demonstrated to interact with λ DNA at the region
of the pR promoter, facilitating repression of this promoter
by the phage-encoded cI protein, and stimulating activation of
the pM promoter (required for the cI repressor production)
(Glinkowska et al., 2010). Both repression of pR and activa-
tion of pM are necessary for prophage maintenance (Ptashne,
2004; We˛grzyn and We˛grzyn, 2005). Importantly, the presence
of a potential OxyR-binding sequence has been identified close
to the cI transcription start site in genomes of various lamb-
doid bacteriophages, including Shiga toxin-converting bacterio-
phages (Glinkowska et al., 2010). Thus, we propose that the
host-encoded OxyR transcription regulator may be employed
by the phage to keep the efficiency of hydrogen peroxide-
dependent prophage induction at a relatively low level. The bac-
terial “altruism” hypothesis might then be supported further if
such regulation were shown to occur in Shiga toxin-converting
prophage.
CONCLUDING REMARKS
Recently, two research groups proposed independently a hypoth-
esis that can explain the bacterial benefit from producing Shiga
toxins, even if production is coupled with prophage induction
and subsequent bacterial cell death (Łos´ et al., 2011; Mauro
and Koudelka, 2011). This hypothesis is depicted in Figure 1.
While it appears that experimental data might not be compat-
ible with this hypothesis, a detailed analysis of the published
data demonstrates that the facts corroborate the hypothesis rather
than disqualify it. Therefore, the “model of STEC altruism” can
be described as follows: outside the mammalian intestine, enteric
bacteria are endangered by protozoan predators, which produce
and release hydrogen peroxide to damage prokaryotic cells, facil-
itating their predation. Such a strategy is efficient against most
bacteria, but STEC strains, bearing prophages with stx genes,
have developed a defensive strategy based on production of
Shiga toxins which can kill eukaryotic cells. Because produc-
tion of Shiga toxins is strongly coupled to prophage induction
and bacterial cell lysis, the efficiency of Shiga toxin-converting
prophage induction must be relatively low, so that a large propor-
tion of the bacterial population survive. In fact, H2O2-mediated
induction of these prophages is of low efficiency, perhaps due
to the activity of the OxyR regulatory protein or some simi-
lar system that enhances prophage maintenance. This low level
prophage induction is, however, sufficient to produce Shiga tox-
ins in amounts large enough to neutralize the predator. If STEC
enters the human intestine, it may be recognized as an alien
organism, and neutrophils may try to kill STEC by producing
hydrogen peroxide and other reactive oxygen species, which
is a strategy analogous to that used by protozoan predators.
The response of STEC to such an action is also analogous to
that employed to neutralize a eukaryotic unicellular predator.
However, in the intestine, a population of STEC may survive
the attack by the human immunological system rather than
the attack of a predator. Since the effects of Shiga toxins on
human cells could be as serious as those on protozoan organ-
isms, severe symptoms may develop in infected humans. At the
same time, a population of Shiga toxin-producing bacteria may
not only survive in the human intestine, but may also be shed
in excrement during diarrhea. It is worth noting that under
these conditions STEC strains are immune to infection by Shiga
toxin-converting bacteriophages as all bacteria lysogenic with
lambdoid phages are resistant to infection by the same phage
(due to a strong repression of phage lytic development by the
cI repressor, present in large amounts in lysogenic cells) (for
the description of the immunity analysis of Shiga toxin-encoding
bacteriophages see Allison et al., 2003; for reviews on other lamb-
doid phages see Ptashne, 2004; We˛grzyn and We˛grzyn, 2005;
Łos´ et al., 2011; We˛grzyn et al., 2012). Therefore, the produc-
tion of progeny virions and their release is not dangerous for
the population of STEC, but facilitate either lysogenization of
other E. coli strains present in the intestine or further propaga-
tion of bacteriophages on such strains if lytic development of
phages is chosen after infection of sensitive bacteria. The lat-
ter scenario could also result in production of larger amounts
of Shiga toxin, which would provide an additional benefit for
STEC. Although it was demonstrated that there are multiple
integrations sites for Shiga toxin-converting phages in E. coli
genomes, and that superinfection of E. coli lysogenized by iso-
genic phages bearing stx genes can occur, such superinfection
leads to lysogeny rather than lysis (Fogg et al., 2007, 2011; Serra-
Moreno et al., 2007, 2008). Therefore, STEC are not endangered
by Shiga toxin-converting phages isogenic to those maintained
in these STEC in the form of prophages. Finally, one might
assume that this bacterial “altruism” hypothesis can be fur-
ther tested experimentally by determining the actual fraction of
STEC cells in which prophage induction occurs following treat-
ment with hydrogen peroxide (the current calculation is based
on the assumption that efficiency of phage progeny production
is equal in every cell after excision of the prophage DNA and
subsequent phage lytic development), and by comparing the effi-
ciency of toxin production in STEC culture and in mixed culture
containing both STEC and other E. coli susceptible to Shiga
toxin-converting phage infection.
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